Health
Study reports promising new monoclonal antibody against SARS-CoV-2’s spike protein – News-Medical.Net
An encouraging new study describes a promising new therapeutic antibody that shows potent neutralizing activity against SARS-CoV-2, the causative agent of COVID-19….
As the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), refuses to subside, the search for effective antivirals and therapeutics continues without respite. An encouraging paper published in the journal Nature Communicationson January 12, 2021, describes a promising new therapeutic antibody that potently neutralizes the virus.
SARS-CoV-2 has its own spike protein that interacts with the human angiotensin-converting enzyme 2 (ACE2)…
-
Business6 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
Business22 hours agoUS markets swung wildly last night. How extreme volatility can be a gift to ASX investors
-
General11 hours agoVolodymyr Zelenskyy claims Chinese soldiers fighting alongside Russians in Ukraine
-
General18 hours agoHow what happens on financial markets affects the broader economy